Latest funding opportunities listed:
"The ADDF-Harrington Scholar Program is dedicated to advancing academic discoveries into medicines for Alzheimer's disease and related dementias. This unique award provides funding and committed project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute. Program includes dedicated support from a team of industry veterans with capabilities that include medicinal chemistry, pharmacology & toxicology, and business development. The expertise of each team is tailored to the specific needs of the project during the two-year award period. "
"Deadlines for letters of intent: April 20, 2020 Deadlines for applications: July 31, 2020"Read More
"The Well-Being in FTD Pilot Grant supports projects that seek to develop non-pharmacological, evidence-based interventions for improving daily quality of life for FTD patients and families, mitigating caregiver burden, or advancing person-centered approaches to FTD care in community and residential settings. Proposals that utilize novel technology-based or technology-assisted approaches to support persons living with FTD or their caregivers are especially encouraged. "
Deadline: April 9, 2020Read More
The Foundation invites applications for basic scientific research directed at early detection, improved treatment modalities, and technological advances that will ultimately improve outcomes for patients with brain aneurysms, as well as projects that are translational, clinical/outcome, early detection, imaging, and SAH/SAH complications focused. Any project with the potential to advance basic scientific, translational, and clinical brain aneurysm research will be considered.
Deadline: May 15, 2020Read More
Fellowships are awarded each year, normally to full professors at Canadian universities and research institutes, who have an outstanding reputation in their area of research. The fellowship provides 2 years of release time (valued at $70,000 per year).
Deadline for Full Application: June 1, 2020Read More
The Canadian Cancer Society (CCS) is issuing a special call for grant applications focused on rare and aggressive uterine cancers, with an emphasis on uterine carcinosarcoma in particular. As a result of a generous donation, there is funding available to support one meritorious application that will impact our understanding of uterine carcinosarcoma and other aggressive uterine cancers, particularly as it relates to the prevention, early detection, diagnosis, and/or treatment of these hard-to-treat cancers.
Deadline: April 6, 2020Read More
"Impact Grants provide funding to support ideas that promote major advancements in research programs, whether at the fundamental discovery stage (such as studies involving model organisms that demonstrate potential for impact) through to applied research (such as patient or population-based proposals). Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, and social and population health research. "
"Deadline for letter of intent: April 29, 2020 Deadline for applications: September 15, 2020"Read More
The purpose of this Request for Applications (RFA) is to develop biomarkers that can support therapeutic development for priority pathways in PD. Specifically, the development of biomarkers for pathways that are known to be affected in PD and are the focus of therapeutic efforts--such as inflammation, mitochondrial function, lysosomal function, autophagy, protein trafficking, and protein handling--would dramatically improve our ability to diagnosis, objectively track the progression of disease, enrich for subject populations, or more precisely detect a treatment response or target engagement. The availability of all these types of biomarkers would transform clinical trial design and assist in the interpretation of the results.
"Deadline for Preliminary Proposal: April 23, 2020 Deadline for Full Proposal: August 11, 2020"Read More
The Target Advancement Program seeks to build conclusive evidence to rationalize biological targets and pathways for Parkinson's disease (PD) therapeutic development. Funding will support projects focused on validating targets and defining pathways implicated in PD pathological processes and/or symptomology. Targets and pathways proposed for study should have a reasonable initial link to PD, such as demonstrated genetic association, altered expression/function of the target in PD-relevant human tissue, and/or prior clinical trial data. When considering validation studies, MJFF prioritizes applications proposing experimental systems and models with high construct validity to hypothesized pathogenic mechanisms in human PD, such as patient-derived material and/or animal models demonstrating dysfunction in the pathway(s) proposed for study.
"Deadline for preliminary proposals: April 23, 2020 Deadline for full proposals: August 11, 2020"Read More
The Therapeutic Pipeline Program seeks to speed the development of Parkinson's disease therapeutics with potential for fundamentally altering disease course, significantly improving treatment or management of non-motor or motor symptoms beyond current standards of care. Proposals should focus on strategies with clear impact for people with Parkinson's and well-defined development plans. Programs developing novel approaches as well as approved or clinically safe repurposed or repositioned therapies from other disease indications are appropriate for this RFA. MJFF will prioritize clinical and pre-clinical approaches built on strong scientific and biological rationale for targeting fundamental processes underlying Parkinson's cause, progression and/or non-motor and motor symptom expression.
"Deadline for Pre-Proposals: April 23, 2020 Deadline for Applications: August 11, 2020"Read More
Michael J. Fox Foundation for Parkinson's Research - Investigating Environmental Factors that Increase the Risk for Parkinson's Disease
"The Investigating Environmental Risk Factors that Increase the Risk for Parkinson's Disease program supports the analysis of large epidemiological datasets to identify environmental risk factors, such as exposure to chemicals, toxic emissions, air pollutants, and dietary contaminants, which are associated with an increased risk of PD. MJFF is especially interested in funding projects that utilize large longitudinal datasets and will prioritize collaborative efforts that bring together teams of investigators with access to multiple diverse datasets. This program is not appropriate for studies that require additional or prospective data collection. "
"Deadline for preliminary proposals: April 23, 2020 Deadline for full proposals: August 11, 2020"Read More
The National Eczema Association (NEA) and the Pediatric Dermatology Research Alliance (PeDRA) are collaborating to support targeted clinical research investigations focused on pediatric eczema with the 2020 Childhood Eczema Challenge Grant. Through this grant NEA and PeDRA intend to accelerate research that improves the health and quality of life of pediatric eczema patients and their families.
Deadline for Applications: May 1, 2020Read More
TS Alliance endeavors to stimulate, support and coordinate research that will lead to a cure for tuberous sclerosis complex (TSC), while improving the lives of those affected.
"Deadline for letter of intent: April 6, 2020 Deadline for full proposals: August 17, 2020"Read More
"Worldwide Cancer Research provides funding for basic and translational research into the prevention, diagnosis or treatment of cancer. Applications on cancer symptoms or treatment side effects are accepted only if there is a very clear link to improving cancer survival. Studies investigating the biology of a side effect or symptom alone are unlikely to be accepted. Basic studies into fundamental cellular processes, mechanisms and molecules are within remit if it is clear that the aim of the research is to improve the understanding of cancer biology. If a project is to study the normal functioning of cellular processes, mechanisms or molecules - or to study very basic models such as yeast - evidence supporting the relevance to cancer biology must be laid out. "
"Deadline: April 3, 2020 Note: Worldwide Cancer Research will only accept the first 500 applications submitted in the grant round. "Read More
To fund scientifically meritorious research focused on BMF diseases. Investigator‐initiated research is encouraged in the areas of congenital or acquired BMF. Studies focused on BMF diseases and their progression to other malignancies, such as leukemia, are acceptable. However, research primarily focused on myeloproliferative neoplasms, leukemia, or other malignancies is discouraged. Stem cell biology studies and translational projects including bone marrow transplantation studies should be clearly related to BMF diseases.
"Deadline for Pre-Applications: May 11, 2020 Deadline for Applications: August 5, 2020"Read More
"The LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Applications submitted to the FY20 LCRP must address one or more of the following Areas of Emphasis: - Identify innovative strategies for the screening and early detection of lung cancer. - Understand the molecular mechanisms of initiation and progression to lung cancer. - Identify innovative strategies for prevention of the occurrence of lung cancer. - Identify innovative strategies for the treatment of lung cancer. - Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer. - Develop or optimize prognostic or predictive markers to assist with therapeutic decision-making. - Understand mechanisms of resistance to treatment (primary and secondary). - Understand contributors to lung cancer development other than tobacco. - Identify innovative strategies for lung cancer care delivery (disparities/clinical management/ surveillance/symptom management). "
"Deadline for pre-applications (Concept Award, Career Development Award, Idea Development Award): forthcoming "Read More
Funding is provided for one year to test innovative, cutting-edge ideas or untested methods, and to gather sufficient preliminary data to apply for longer-term funding. Researchers who have completed their post-doctoral training, and who are considered eligible by their institutions to apply for a research grant, are invited to apply.
"Deadline for pre-application: May 4, 2020 Deadline for application: May 6, 2020"Read More
BDSRA seeks letters of intent from the Batten and larger lysosomal disease research community for innovative technologies in biomarkers for any of the 14 forms of Batten disease. Development of, or improvement of biomarkers using tissue, blood, urine or imaging are welcome, as are new concepts in development.
Deadline for Letter of Intent: March 27, 2020Read More
"Clinical Research Awards are offered to provide support for investigator-initiated clinical research projects that have the potential to make an important contribution to the CF Foundation's mission. Research projects may address diagnosis, treatment, management of disease or symptom, or the pathophysiology of CF using clinical (observational/interventional), translational or epidemiologic study approaches. "
Deadlines for letters of intent: March 27, 2020; July 17, 2020Read More
"The sponsor supports world-class research, worldwide, to increase understanding of the causes and consequences of Epidermolysis Bullosa (EB), and to develop the evidence base for the development of better clinical care, diagnostics, and disease-modifying therapies for those with EB. The overall objective is to find a cure and therapies for people living with Epidermolysis Bullosa. "
Deadline: April 6, 2020Read More
The mandate of the Canadian Liver Foundation is to provide support for research and education into the causes, diagnosis, prevention and treatment of diseases of the liver.
Deadline: March 31, 2020Read More
"The Lymphoma Canada Research Grants are intended to support small, well-defined research studies that have the potential to effect improvements in healthcare, health systems, and/or health outcomes as they pertain to malignant lymphoproliferative diseases. "
Deadline: April 17, 2020Read More
"The Morton Cure Paralysis Fund (MCPF) is committed to developing effective therapies (cures) for paralysis associated with spinal cord injury and other disorders of the central nervous system (CNS). "
Deadlines: April 30, 2020; October 31, 2020Read More
"The Sanfilippo Children's Foundation funds research that shows potential to contribute to its vision of finding a cure in time for children battling Sanfilippo today, and those born with it tomorrow. The Foundation is particularly interested in three focus areas: - Halt disease progression through therapies such as enzyme replacement, gene therapy and cell therapy and strategies to enhance the effectiveness of such emerging therapies. - Repair and reverse the cell damage caused by Sanfilippo which could include the application of neuroregeneration advances made for other neurodegenerative diseases. - Improve quality of life through palliative care and symptom management specific to Sanfilippo Syndrome. "
"Deadline for Expression of Interest: March 24, 2020 Deadline for Application: May 12, 2020"Read More
"The Foundation's support of health research is offered in through the following programs:
- Health Research Grants
- Healthcare Research by Community Physicians
- Educational Fellowships for Practicing Physicians
- Resident Research Grants
- P.S.I.F. Fellowship for Translational Research
"Deadline: Continuous Note: Applications to PSI Foundation from London researchers are generally submitted through the Lawson Health Research Institute. Contact Lawson <firstname.lastname@example.org> for more information."Read More
Last updated: March 12, 2020
Western researchers can consult Pivot , a comprehensive database of grant information.